CVS Health (CVS) Tops Q2 EPS by 8c; Confirms FY23 Adj EPS

CVS Health (NYSE: CVS) reported Q2 EPS of $2.21, $0.08 better than the analyst estimate of $2.13. Revenue for the quarter came in at $88.92 billion versus the consensus estimate of $86.41 billion.

GUIDANCE:

CVS Health sees FY2023 EPS of $8.50-$8.70, versus the consensus of $8.59.

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance